Axillary Response to Neoadjuvant Therapy in Node-Positive, Estrogen Receptor Positive, HER2 Negative Breast Cancer Patients

被引：0
|
作者：
Friedman-Eldar, O. [1 ]
Ozmen, T. [1 ]
Reyes, F. Valle [1 ]
Goel, N. [1 ]
Tjendra, Y. [1 ]
Moller, M. [1 ]
Kesmodel, S. B. [1 ]
Franceschi, D. [1 ]
Avisar, E. [1 ]
机构：
[1] Univ Miami, Jackson Mem Hosp, Miami, FL 33136 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P59
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [21] Targeted axillary dissection after neoadjuvant systemic therapy in patients with node-positive breast cancer
    Kanesalingam, Kavitha
    Sriram, Nina
    Heilat, Ghaith
    Ng, E-Ern
    Meybodi, Farid
    Elder, Elisabeth
    Brennan, Meagan
    French, James
    ANZ JOURNAL OF SURGERY, 2020, 90 (03) : 332 - 338
  • [22] Neoadjuvant zanidatamab for stage I node negative HER2 positive breast cancer
    Valero, Vicente
    Mouabbi, Jason
    Alonzo, Heather
    Pohlmann, Paula
    Lheme, Adaeze
    Hassan, Amy
    Murthy, Rashmi
    Huang, Xuelin
    Qiao, Wei
    Patel, Miral
    Rauch, Gaiane
    Checka, Cristina
    Symmans, W. Fraser
    Hunt, Kelly
    Tripathy, Debu
    Meric-Bernstam, Funda
    CANCER RESEARCH, 2024, 84 (09)
  • [23] Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer
    Vila, Jose
    Mittendorf, Elizabeth A.
    Farante, Gabriel
    Bassett, Roland L.
    Veronesi, Paolo
    Galimberti, Viviana
    Peradze, Nicolas
    Stauder, Michael C.
    Chavez-MacGregor, Mariana
    Litton, Jennifer F.
    Huo, Lei
    Kuerer, Henry M.
    Hunt, Kelly K.
    Caudle, Abigail S.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (11) : 3501 - 3509
  • [24] Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer
    Jose Vila
    Elizabeth A. Mittendorf
    Gabriel Farante
    Roland L. Bassett
    Paolo Veronesi
    Viviana Galimberti
    Nicolas Peradze
    Michael C. Stauder
    Mariana Chavez-MacGregor
    Jennifer F. Litton
    Lei Huo
    Henry M. Kuerer
    Kelly K. Hunt
    Abigail S. Caudle
    Annals of Surgical Oncology, 2016, 23 : 3501 - 3509
  • [25] Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer
    Gwark, Sungchan
    Noh, Woo Chul
    Ahn, Sei Hyun
    Lee, Eun Sook
    Jung, Yongsik
    Kim, Lee Su
    Han, Wonshik
    Nam, Seok Jin
    Gong, Gyungyub
    Kim, Seon-Ok
    Kim, Hee Jeong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] Association of mammography and ultrasound features with MammaPrint in patients with estrogen receptor-positive, HER2-negative, node-positive invasive breast cancer
    Choi, Woo Jung
    Sim, Hayan
    Kim, Hee Jeong
    Cha, Joo Hee
    Shin, Hee Jung
    Chae, Eun Young
    Kim, Hak Hee
    ACTA RADIOLOGICA, 2021, 62 (12) : 1592 - 1600
  • [27] Predictive Biomarker of Response to Neoadjuvant Therapy in HER2 Positive Breast Cancer
    Zhao, Jing
    Meisel, Jane
    Suo, Aili
    Zhang, Chao
    Wei, Zhimin
    Aneja, Ritu
    Li, Zaibo
    Nahta, Rita
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2019, 99
  • [28] Neoadjuvant Therapy and Axillary Lymph Node Status in HER2-Positive Breast Cancer
    Danzinger, Sabine
    Pfeifer, Christian
    Wimmer, Sophia
    Tendl-Schulz, Kristina
    Singer, Christian F.
    CANCER INVESTIGATION, 2023, 41 (06) : 593 - 600
  • [29] Axillary Lymph Node Status and neoadjuvant Therapy in HER2-positive Breast Cancer
    Danzinger, S.
    Pfeifer, C.
    Wimmer, S.
    Tendl-Schulz, K.
    Singer, C. F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (04) : E3 - E3
  • [30] Outcomes for sentinel node-positive breast cancer patients following neoadjuvant therapy without axillary node dissection
    Ellis, Kimberly
    Patterson, Anne
    Wong, Jasmine
    Mukhtar, Rita
    Ewing, Cheryl
    Esserman, Laura
    Alvarado, Michael
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 319 - 319
12345